Over time left ventricular assist devices (LVAD) have become an alternative to heart transplantation because of enormous technical development and miniaturization. Most patients present a significant improvement in clinical conditions and exercise capacity. Nevertheless, exercise tolerance remains markedly limited even after LVAD implantation compared to a control group. The complex physiological and hemodynamic changes in LVAD patients, both at rest and during exercise, are not yet understood, or at least not completely.
It is the aim of the present paper to describe the current state of scientific knowledge. Furthermore, the spectrum of diagnostic tools, including the noninvasive inert gas rebreathing method for measurement of cardiac output and associate parameters, are discussed. Options for training control in this special patient group are presented.
BuiA.L., HorwichT.B., FonarowG.C.Epidemiology and risk profile of heart failure.Nat Rev Cardiol.2011; 8(1): 30–41.
2.
MosterdA., HoesA.W.Clinical epidemiology of heart failure.Heart.2007; 93(9): 1137–1146.
3.
SlaughterM.S., RogersJ.G., MilanoC.A., et al; HeartMate II Investigators. Advanced heart failure treated with continuous-flow left ventricular assist device.N Engl J Med.2009; 361(23): 2241–2251.
4.
RogersJ.G., AaronsonK.D., BoyleA.J., et al; HeartMate II Investigators. Continuous flow left ventricular assist device improves functional capacity and quality of life of advanced heart failure patients.J Am Coll Cardiol.2010; 55(17): 1826–1834.
5.
ParkS.J., MilanoC.A., TatoolesA.J., et al; HeartMate II Clinical Investigators. Outcomes in advanced heart failure patients with left ventricular assist devices for destination therapy.Circ Heart Fail.2012; 5(2): 241–248.
6.
SchmittoJ.D., HankeJ.S., RojasS.. Circulatory support exceeding five years with a continuous-flow left ventricular assist device for advanced heart failure patients.J Cardiothorac Surg.2015; 10: 107.
7.
BentonC.R., SaverG., NairA.P.. Left ventricular assist devices improve functional class without normalizing peak oxygen consumption.ASAIO J.2015; 61(3): 237–243.
8.
ReissN., AltesellmeierM., MommertzS., SchmidtT., Schulte-EistrupS., WillemsenD.Hämodynamik und körperliche Belastbarkeit bei Patienten mit Linksherzunterstützungssystem.Herz.2016; 41: 507.
9.
HatanoM., KinugawaK., ShigaT.. Less frequent opening of the aortic valve and a continuous flow pump are risk factors for postoperative onset of aortic insufficiency in patients with a left ventricular assist device.Circ J.2011; 75(5): 1147–1155.
10.
PatangiS.O., GeorgeA., PauliH.. Management issues during HeartWare left ventricular assist device implantation and the role of transesophageal echocardiography.Ann Card Anaesth.2013; 16(4): 259–267.
11.
SunX.G., HansenJ.E., StringerW.W., TingH., WassermanK.Carbon dioxide pressure-concentration relationship in arterial and mixed venous blood during exercise.J Appl Physiol (1985).2001; 90(5): 1798–1810.
12.
AgostoniP., CattadoriG., ApostoloA.. Noninvasive measurement of cardiac output during exercise by inert gas rebreathing technique: a new tool for heart failure evaluation.J Am Coll Cardiol.2005; 46(9): 1779–1781.
13.
ChristensenP., ClemensenP., AndersenP.K., HennebergS.W.Thermodilution versus inert gas rebreathing for estimation of effective pulmonary blood flow.Crit Care Med.2000; 28(1): 51–56.
14.
DamgaardM., NorskP.Effects of ventilation on cardiac output determined by inert gas rebreathing.Clin Physiol Funct Imaging.2005; 25(3): 142–147.
15.
FontanaP., BoutellierU., ToigoM.Reliability of measurements with Innocor during exercise.Int J Sports Med.2009; 30(10): 747–753.
16.
FontanaP., BoutellierU., ToigoM.Non-invasive haemodynamic assessments using Innocor during standard graded exercise tests.Eur J Appl Physiol.2010; 108(3): 573–580.
17.
GabrielsenA., VidebaekR., SchouM., DamgaardM., KastrupJ., NorskP.Non-invasive measurement of cardiac output in heart failure patients using a new foreign gas rebreathing technique.Clin Sci.2002; 102(2): 247–252.
18.
LangC.C., KarlinP., HaytheJ., TsaoL., ManciniD.M.Ease of noninvasive measurement of cardiac output coupled with peak VO2 determination at rest and during exercise in patients with heart failure.Am J Cardiol.2007; 99(3): 404–405.
19.
SaurJ., FluechterS., TrinkmannF.. Noninvasive determination of cardiac output by the inert-gas-rebreathing method-comparison with cardiovascular magnetic resonance imaging.Cardiology.2009; 114(4): 247–254.
20.
JacquetL., VancaenegemO., PasquetA.. Exercise capacity in patients supported with rotary blood pumps is improved by a spontaneous increase of pump flow at constant pump speed and by a rise in native cardiac output.Artif Organs.2011; 35(7): 682–690.
21.
BrassardP., JensenA.S., NordsborgN.. Central and peripheral blood flow during exercise with a continuous-flow left ventricular assist device: constant versus increasing pump speed: a pilot study.Circ Heart Fail.2011; 4(5): 554–560.
22.
LeibnerE.S., CysykJ., EleuteriK., El-BanayosyA., BoehmerJ.P., PaeW.E.Changes in the functional status measures of heart failure patients with mechanical assist devices.ASAIO J.2013; 59(2): 117–122.
23.
LevineB.D., CornwellWKIII, DraznerM.H.Factors influencing the rate of flow through continuous-flow left ventricular assist devices at rest and with exercise.JACC Heart Fail.2014; 2(4): 331–334.
24.
MartinaJ., de JongeN., RuttenM.. Exercise hemodynamics during extended continuous flow left ventricular assist device support: the response of systemic cardiovascular parameters and pump performance.Artif Organs.2013; 37(9): 754–762.
25.
SalamonsenR.F., PellegrinoV., FraserJ.F.. Exercise studies in patients with rotary blood pumps: cause, effects, and implications for starling-like control of changes in pump flow.Artif Organs.2013; 37(8): 695–703.
26.
MuthiahK., GuptaS., OttonJ.. Body position and activity, but not heart rate, affect pump flows in patients with continuous-flow left ventricular assist devices.JACC Heart Fail.2014; 2(4): 323–330.
27.
McKellarS.H., DeoS., DalyR.C.. Durability of central aortic valve closure in patients with continuous flow left ventricular assist devices.J Thorac Cardiovasc Surg.2014; 147(1): 344–348.
28.
CompostellaL., RussoN., SetzuT., CompostellaC., BellottoF.Exercise performance of chronic heart failure patients in the early period of support by an axial-flow left ventricular assist device as destination therapy.Artif Organs.2014; 38(5): 366–373.
29.
DimopoulosS., DiakosN., TseliouE.. Chronotropic incompetence and abnormal heart rate recovery early after left ventricular assist device implantation.Pacing Clin Electrophysiol.2011; 34(12): 1607–1614.
30.
DunlayS.M., AllisonT.G., PereiraN.L.Changes in cardiopulmonary exercise testing parameters following continuous flow left ventricular assist device implantation and heart transplantation.J Card Fail.2014; 20(8): 548–554.
31.
HaftJ., ArmstrongW., DykeD.B.. Hemodynamic and exercise performance with pulsatile and continuous-flow left ventricular assist devices.Circulation.2007; 116(11)(Suppl): I8–I15.
32.
HayesK., LeetA.S., BradleyS.J., HollandA.E.Effects of exercise training on exercise capacity and quality of life in patients with a left ventricular assist device: a preliminary randomized controlled trial.J Heart Lung Transplant.2012; 31(7): 729–734.
33.
JakovljevicD.G., BirksE.J., GeorgeR.S.. Relationship between peak cardiac pumping capability and selected exercise-derived prognostic indicators in patients treated with left ventricular assist devices.Eur J Heart Fail.2011; 13(9): 992–999.
34.
JakovljevicD.G., GeorgeR.S., NunanD.. The impact of acute reduction of continuous-flow left ventricular assist device support on cardiac and exercise performance.Heart.2010; 96(17): 1390–1395.
35.
JungM.H., HansenP.B., SanderK.. Effect of increasing pump speed during exercise on peak oxygen uptake in heart failure patients supported with a continuous-flow left ventricular assist device. A double-blind randomized study.Eur J Heart Fail.2014; 16(4): 403–408.
36.
KerriganD.J., WilliamsC.T., EhrmanJ.K.. Muscular strength and cardiorespiratory fitness are associated with health status in patients with recently implanted continuous-flow LVADs.J Cardiopulm Rehabil Prev.2013; 33(6): 396–400.
37.
KuglerC., MalehsaD., SchraderE.. A multi-modal intervention in management of left ventricular assist device outpatients: dietary counselling, controlled exercise and psychosocial support.Eur J Cardiothorac Surg.2012; 42(6): 1026–1032.
38.
NoorM.R., BowlesC., BannerN.R.Relationship between pump speed and exercise capacity during HeartMate II left ventricular assist device support: influence of residual left ventricular function.Eur J Heart Fail.2012; 14(6): 613–620.
39.
DangN.C., TopkaraV.K., MercandoM.. Right heart failure after left ventricular assist device implantation in patients with chronic congestive heart failure.J Heart Lung Transplant.2006; 25(1): 1–6.
40.
MatthewsJ.C., KoellingT.M., PaganiF.D., AaronsonK.D.The right ventricular failure risk score a pre-operative tool for assessing the risk of right ventricular failure in left ventricular assist device candidates.J Am Coll Cardiol.2008; 51(22): 2163–2172.
41.
SabashnikovA., MohiteP.H., ZychB.. Outcomes and predictors of early mortality after continuous-flow left ventricular assist device implantation as a bridge to transplantation.ASAIO J.2014; 60(2): 162–169.
42.
MorganJ.A., PaoneG., NemehH.W.. Impact of continuous-flow left ventricular assist device support on right ventricular function.J Heart Lung Transplant.2013; 32(4): 398–403.
WillemsenD., CordesC., Bjarnason-WehrensB.. Rehabilitationsstandards für die Anschlussheilbehandlung und allgemeine Rehabilitation von Patienten mit einem Herzunterstützungssystem (VAD - ventricular assist device).Clin Res Cardiol Suppl.2016; 11(Suppl 1): 2–49.
45.
ATS Committee on Proficiency Standards for Clinical Pulmonary Function Laboratories.ATS statement: guidelines for the six-minute walk test.Am J Respir Crit Care Med.2002; 166(1): 111–117.
46.
LöllgenH., UlmerH.„DasäGespräch” während der Ergometrie: Die Borg-Skala.Dtsch Arztebl.2004; 101(15): A-1014/B-838/C-819. http://www.aerzteblatt.de/archiv/41324. Accessed October 26, 2016.
47.
PodsiadloD., RichardsonS.The timed Up & Go: a test of basic functional mobility for frail elderly persons.J Am Geriatr Soc.1991; 39(2): 142–148.
48.
InnesE.Handgrip strength testing: A review of the literature.Aust Occup Ther J.1999; 46(3): 120–140.
49.
ChungC.J., WuC., JonesM.. Reduced handgrip strength as a marker of frailty predicts clinical outcomes in patients with heart failure undergoing ventricular assist device placement.J Card Fail.2014; 20(5): 310–315.
50.
ScheidererR., BeldenC., SchwabD., HaneyC., PazJ.Exercise guidelines for inpatients following ventricular assist device placement: a systematic review of the literature.Cardiopulm Phys Ther J.2013; 24(2): 35–42.
51.
FeldmanD., PamboukianS.V., TeutebergJ.J., et al; International Society for Heart and Lung Transplantation. The 2013 International Society for Heart and Lung Transplantation Guidelines for mechanical circulatory support: executive summary.J Heart Lung Transplant.2013; 32(2): 157–187.
52.
PiepoliM.F., ConraadsV., CorràU.. Exercise training in heart failure: from theory to practice. A consensus document of the Heart Failure Association and the European Association for Cardiovascular Prevention and Rehabilitation.Eur J Heart Fail.2011; 13(4): 347–357.
53.
MarkoC.. Safety and efficacy of cardiac rehabilitation for patients with continuous flow left ventricular assist devices.Eur J Prev Cardiol.2015; 22(11): 1378–84.
54.
VanheesL., RauchB., PiepoliM., et al; Writing Group, EACPR. Importance of characteristics and modalities of physical activity and exercise in the management of cardiovascular health in individuals with cardiovascular disease (Part III).Eur J Prev Cardiol.2012; 19(6): 1333–1356.
55.
GiannuzziP., TemporelliP.L., CorràU., TavazziL.; ELVD-CHF Study Group. Antiremodeling effect of long-term exercise training in patients with stable chronic heart failure: results of the Exercise in Left Ventricular Dysfunction and Chronic Heart Failure (ELVD-CHF) Trial.Circulation.2003; 108(5): 554–559.
56.
AlsaraO., Perez-TerzicC., SquiresR.W., et al.Is exercise training safe and beneficial in patients receiving left ventricular assist device therapy? J Cardiopulm Rehabil Prev.2014; 34(4): 233–240.
57.
LaoutarisI.D., DritsasA., AdamopoulosS.. Benefits of physical training on exercise capacity, inspiratory muscle function, and quality of life in patients with ventricular assist devices long-term postimplantation.Eur J Cardiovasc Prev Rehabil.2011; 18(1): 33–40.
58.
KarapolatH., EnginC., ErogluM.. Efficacy of the cardiac rehabilitation program in patients with end-stage heart failure, heart transplant patients, and left ventricular assist device recipients.Transplant Proc.2013; 45(9): 3381–3385.
59.
MezzaniA.. Systemic perfusion at peak incremental exercise in left ventricular assist device recipients: Partitioning pump and native left ventricle relative contribution.IJC Heart & Vessels.2014; 4: 40–45.
60.
WonischM., FruhwaldF.M., HofmannP.. Spiroergometrie in der Kardiologie- Grundlagen der Physiologie und Terminologie.J Kardiol.2003; 10(9): 383–390.
61.
TrappeH.J., LöllgenH.Leitlinien zur Ergometrie.Z Kardiol.2000; 89(9): 821–831.
62.
FessE.The effect of Jamar dynamometer handle position and test protocol on normal grip strength.J Hand Surg Am.1982; 7: 308–309.
63.
MarschallF., GailS.Standardisierung eines Testprotokolls zur Bestimmung der isometrischen Maximalkraft.Bewegungstherapie und Gesundheitssport2011; 27(06): 226–230.
